Table 6

Recurrences overall and by stage (I, II, and III) compared with the status of BRCA1 loss of heterozygosity (LOH)

Informative cases (%)With LOH (%)Without LOH (%)p Value
Overall recurrences
    Yes51 (23.8)31 (60.8)20 (39.2)0.0003
    No163 (76.2)53 (32.5)110 (67.5)
Stage I
    Yes5 (17.2)5 (100)00.008
    No24 (82.8)6 (25)18 (7.5)
Stage II
    Yes14 (14.6)10 (71.4)4 (28.6)0.01
    No82 (85.4)26 (31.7)56 (68.3)
Stage III
    Yes32 (36)16 (50)16 (50)0.32
    No57 (64)21 (36.8)36 (73.2)